Chemotherapy Plus EGFR-TKI as First-Line Treatment Provides Better Survival for Advanced EGFR-Positive Lung Adenocarcinoma Patients: Updated Data and Exploratory In Vitro Study-MedSci.cn

Chemotherapy Plus EGFR-TKI as First-Line Treatment Provides Better Survival for Advanced EGFR-Positive Lung Adenocarcinoma Patients: Updated Data and Exploratory In Vitro Study

Lou, YQ; Xu, JL; Zhang, YW; Lu, J; Chu, TQ; Zhang, XY; Wang, HM; Zhong, H; Zhang, W; Han, BH

Zhang, W; Han, BH (corresponding author), Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Pulm Med, 241 West Huaihai Rd, Shanghai 200030, Peoples R China.

TARGETED ONCOLOGY, 2020; 15 (2): 175

Abstract

Background Previously, we demonstrated that treatment with gefitinib combined with pemetrexed plus carboplatin chemotherapy improved progression-free ......

Full Text Link